Patents by Inventor Valerie Burland

Valerie Burland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING REDUCED GENOME BACTERIA FOR USE IN TREATMENT OF SEPSIS
    Publication number: 20120093865
    Abstract: Methods for prophylaxis or treatment of sepsis in a subject are provided comprising administering to the subject a therapeutically effective dose of multiple deletion strain bacteria.
    Type: Application
    Filed: February 10, 2010
    Publication date: April 19, 2012
    Applicant: SCARAB GENOMICS LLC
    Inventors: Frederick Blattner, Valerie Burland, John Campbell, Charles Landry
  • COMPOSITIONS COMPRISING REDUCED GENOME BACTERIA FOR USE IN TREATMENT OF SEPSIS
    Publication number: 20110293662
    Abstract: Methods for prophylaxis or treatment of sepsis in a subject are provided comprising administering to the subject a therapeutically effective dose of multiple deletion strain bacteria.
    Type: Application
    Filed: February 10, 2010
    Publication date: December 1, 2011
    Applicant: SCARAB GENOMICS LLC
    Inventors: Frederick R. Blattner, Valerie Burland, John Walter Campbell, Charles Landry
  • Sequences of E. coli O157
    Patent number: 6855814
    Abstract: The entire genome of pathogenic E. coli strain 0157:H7 has been sequenced. All of the genomic DNA sequences present in 0157 and absent in the previously sequenced laboratory strain K12 are presented here.
    Type: Grant
    Filed: April 1, 2002
    Date of Patent: February 15, 2005
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Frederick R. Blattner, Valerie Burland, Nicole T. Perna, Guy Plunkett, Rod Welch
  • Plasmid DNA from Yersinia pestis
    Patent number: 6706522
    Abstract: The complete DNA sequence of three plasmids from the bacterium Yersinia pestis, the causative agent for bubonic plague, have been determined and are set forth. The open reading frames, or protein coding regions, of the plasmids have been determined. The DNA sequence and ORF information is useful for the creation of diagnostic, prophylactic and therapeutic tools for combating the disease caused by this agent.
    Type: Grant
    Filed: September 30, 1999
    Date of Patent: March 16, 2004
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Frederick R. Blattner, Valerie Burland, Debra J. Rose, George F. Mayhew, Nicole Perna, Robert D Perry, Susan C Straley, Jacqueline D. Fetherston, Luther E. Lindler, Gregory V. Plano
  • Sequences of E. coli O157
    Patent number: 6365723
    Abstract: The entire genome of pathogenic E. coli strain O157:H7 has been sequenced. All of the genomic DNA sequences present in O157 and absent in the previously sequenced laboratory strain K12 are presented here.
    Type: Grant
    Filed: December 3, 1999
    Date of Patent: April 2, 2002
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Frederick R. Blattner, Valerie Burland, Nicole T. Perna, Guy Plunkett, Rod Welch